title: Therapeutic options in mantle cell lymphoma.
abstract: Mantle cell lymphoma (MCL) is an aggressive lymphoma requiring intensive chemotherapy +/- autologous stem cell transplantation (SCT) to achieve optimal rates of progression-free survival. Here we review the treatment options for patients with newly-diagnosed or relapsed MCL and discuss recent advances in management, including the role of autologous and allogeneic SCT.
authors.affiliation: Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre.
authors.forename: Saar
authors.initials: S
authors.lastname: Gill
authors.forename: David
authors.initials: D
authors.lastname: Ritchie
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000628:therapy*; D016239:MEDLINE; D016499:Radioimmunotherapy / Q000379:methods; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents